Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07731451

The Role of Brain Lactate Metabolism in Neuroprotection During Healthy Aging

The brain's primary source of fuel is glucose. Unfortunately, the brain's ability to use glucose declines during normal aging. This decline in brain glucose metabolism makes it vulnerable to cognitive impairment and Alzheimer's disease. The brain can use another fuel source - lactate - which becomes available to the brain during exercise. The investigators have discovered that when lactate fuels the brain, brain glucose metabolism also improves. Essentially, from a metabolic angle, the brain appears younger. Recently, the investigators have shown that lactate - even in the absence of exercise - stimulates this beneficial effect on the brain. The investigators propose to compare the effects of lactate in healthy young and older adults to test whether these beneficial lactate-mediated effects persist throughout the lifespan, thereby providing a blueprint to restore youthful brain glucose metabolism.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Northern Arizona University Dept of Biological Sciences

Flagstaff, Arizona, 86011, United States

Location contact

TRAVIS GIBBONS, PhD

CONTACT

[email protected]

7785836976

About this study

The human brain has an immense energy demand that is fueled almost exclusively by glucose. Unfortunately, the brain's ability to metabolize glucose declines with age, and this is linked to neurodegenerative diseases. Finding ways to delay, halt, or reverse brain glucose hypo-metabolism is fundamental to promoting healthy brain aging. Exercise is a well-established way to improve brain glucose metabolism. The investigators have discovered a mechanism through exercise to selectively upregulate aerobic glycolysis - the specific pathway that is responsible for the age-related decline in whole brain glucose metabolism. Aerobic glycolysis is a unique form of glucose metabolism that does not undergo oxidative phosphorylation despite sufficient oxygen availability, and is essential during brain activation, learning, and memory formation, and is highest in the early stages of life when synaptic plasticity and growth are occurring at rapid rates. Preserving aerobic glycolysis during aging protects against Alzheimer's disease. The investigators have developed an experimental model that reproducibly upregulates aerobic glycolysis in a controlled manner using infusion of lactate - an alternative and preferred fuel for the brain. Whether lactate is increased passively via infusion, or actively via exercise, aerobic glycolysis is promoted, indicating that lactate may well be the key to activating brain aerobic glycolysis during exercise. The investigators objective is to exploit this unique role of lactate to evaluate changes in brain metabolism during healthy aging. The specific aims are to test whether aerobic glycolysis can be upregulated via lactate similarly in young and older healthy individuals and determine if age influences the neurotrophic and cognitive benefits afforded by lactate in young adults. The approach is to combine our invasive cross-brain blood sampling technique with stable isotope tracers to directly quantify brain substrate metabolism during exercise and lactate infusion in healthy young adults (aged 20-30) and healthy older adults (aged 65-80). This contribution is significant since aerobic glycolysis is a metabolic signature of a young, resilient brain. Identifying ways to naturally upregulate aerobic glycolysis throughout the lifespan will provide a framework to build therapies targeted toward healthy brain aging.

The general purpose is to characterize brain metabolism during healthy aging. The investigators will do this by directly assessing brain fuel metabolism in young and older humans in response to two interventions: 1) exercise, and 2) lactate infusion, both of which challenge the brain to use alternative fuels. It is hypothesized that: 1) when made available to the brain, lactate will spare glucose for aerobic glycolysis (a beneficial metabolic pathway) and stimulate the production of neurotrophic factors in the brain, and 2) that this metabolic 'flexibility' to upregulate aerobic glycolysis will be preserved in healthy aging. Generally, the investigators will test if this youthful pattern of aerobic glycolysis can be resurrected late in life through acute exercise. The specific aims are:

  • Determine if increasing circulating lactate - passively via infusion and actively via exercise - translates to increased brain lactate metabolism equally in otherwise healthy young and elderly humans, i.e., brain is metabolic flexibility preserved across the lifespan?
  • Verify that increasing brain lactate metabolism causes a proportional decrease in glucose oxidation, thus providing evidence for a glucose-sparing effect of lactate, and;
  • Determine if lactate causes a similar neurotrophic and cognitive effect in healthy young and elderly humans, i.e., does exercise permit the same brain benefits throughout the lifespan?

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Meet the American College of Sports Medicine (ACSM) physical activity guidelines for moderate-intensity aerobic activity, i.e., 150+ minutes of moderate or 75+ minutes of rigorous aerobic activity.
  • The older cohort must have adhered to these physical activity guidelines for 30+ years.
  • "Good" or "Excellent" aerobic fitness category based on ACSM standardized maximal aerobic power (V̇O2max) values for age and sex.

Exclusion criteria

  • Need for daily medication for chronic conditions, diagnosed heart, lung, metabolic or cerebrovascular disease, smokers, pregnancy and women in perimenopause are exclusion criteria; these will be verified with questionnaires and preliminary screening.
  • Significant carotid plaque will be excluded via ultrasound assessment.
  • Evidence of mild cognitive impairment (MCI)
  • Personal complaints of memory deficits, clinical diagnosis, or evidence from the NIH ToolBox ®V3 will be considered signs of MCI.
  • Adverse responses to maximal exercise, or an inability to complete maximal exercise during fitness screening will also be exclusion criteria.
  • known allergy to Lidocaine also cannot participate.

Treatment and study plan

Sodium lactate infusion

Biological

Sodium lactate will be infused to target circulating concentrations between 4-6 mmol/L

Exercise-induced hyperlactatemia

Other

Cycling will be performed at an intensity to increase circulating lactate to 4-6 mmol/L

Primary outcomes

  1. Cerebral metabolism

    Time frame: -Pre-intervention in rested state -During intervention when lactate is experimentally elevated -After recovery from intervention

    Lactate, glucose and oxygen metabolism via stable isotope tracers and Fick method using arterial and internal jugular venous blood sampling in combination with cerebral blood flow via ultrasound. These will be quantified as rates in grams/minute or mililiters/minute.

Secondary outcomes

  1. Brain-specific biomarkers

    Time frame: -Pre-intervention in rested state -During intervention when lactate is experimentally elevated -After recovery from intervention

    Brain-derived neurotrophic factor, secreted amyloid-b precursor protein and platelet factor-4 will be quantified from concentrations measured in blood entering and exiting the brain via sampling from arterial and internal jugular venous blood.

  2. Cognitive function

    Time frame: -Pre-intervention in rested state -During intervention when lactate is experimentally elevated -After recovery from intervention

    Several domains of cognitive function will be assessed using NIH ToolBox V3.

Study contacts

Contact information is provided by the study sponsor or research team.

TRAVIS GIBBONS, PhD

CONTACT

[email protected]

17785836976

Tinna Traustadottir, PhD

CONTACT

[email protected]

9282558768

Sponsors and collaborators

Lead sponsor

Northern Arizona University

Other

Registry information

Official study title

Effects of Lactate on Brain Carbohydrate Metabolism in Healthy Aging

Important dates

Study start
2027
Primary completion
2028
Study completion
2029
First posted
Jul 28, 2026
Registry last updated
Jul 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.